| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 04/30/2008 | CN101168526A 9-ethyl-3-carbazolmethylene-carbazolhydrazone and application thereof in detecting content of nitrite ion in solution |
| 04/30/2008 | CN101168134A Nanometer structure cinchona alkaloid thiourea multi-phase bionic catalyst and preparation method thereof |
| 04/30/2008 | CN100384823C Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 04/30/2008 | CN100384820C Phosphate prodrugs of fluorooxindoles |
| 04/30/2008 | CN100384482C Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 04/29/2008 | US7365216 Process for the production of citalopram |
| 04/29/2008 | US7365205 Diamine derivatives |
| 04/29/2008 | US7365124 Flame retardant resin blends based on polymers derived from 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers |
| 04/29/2008 | US7365091 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX |
| 04/29/2008 | US7365090 Substituted phenylindoles for the treatment of HIV |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365076 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365061 Antidiabetic agents, anticancer, non-cardiac ischemia, infection, hypertension, obesity and dislipidemia; 3-(5-chloroindole-2-carbonylamino)-2-hydroxy-1,2,3,4-tetrahydronaphthalene |
| 04/29/2008 | CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/29/2008 | CA2245484C Novel urea derivatives |
| 04/28/2008 | CA2666880A1 Organic compounds |
| 04/24/2008 | WO2008049116A2 Substituted indoles |
| 04/24/2008 | WO2008048981A2 Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 04/24/2008 | WO2008047839A1 5-ht1a receptor agonist |
| 04/24/2008 | WO2008047831A1 Jak inhibitor |
| 04/24/2008 | WO2008046798A1 Isoindol derivatives as ep4 receptor agonists |
| 04/24/2008 | WO2008023336A3 Matrix metalloproteinase inhibitors |
| 04/24/2008 | WO2008009415A3 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 04/24/2008 | US20080096999 chlorinated subphthalocyanine coordinated with boron trichloride; ink for color filter; blue-colored pixels of excellent lightfastness, solvent resistance and heat resistance; brightnesss; saturation; kneading with alcohol solvent and inorganic salt (NaCl): narrow particle size distribution |
| 04/24/2008 | US20080096954 Novel Bicyclic Compounds As Modulators of Androgen Receptor Function And Method |
| 04/24/2008 | US20080096953 N-(2-{2-[(2-Hydroxy-3-isobutyl-3-methyl-4-oxo-cyclobut-1-enyl)-phenyl-methyl]-6-methyl-1H-indol-3-yl}-1,1-dimethyl-ethyl)-acetamide, for example; useful as chymase inhibitors; treatment of allergy, asthma, peripheral arterial occlusive disease, irritable bowel disease |
| 04/24/2008 | US20080096952 Methods for the treatment of atherosclerosis, using substituted phenethylsulfones |
| 04/24/2008 | US20080096951 Carvedilol Monocitrate Monohydrate |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096913 peroxisome proliferator-activated receptor agonists; congestive heart failure, atherosclerosis, arteriosclerosis, obesity, hyperlipidemia, hypoalphalipoproteinemia, Syndrome X, diabetes, insulin resistance; 3-[5-Methoxy-1-(3-methoxy-benzyl)-1H-indol-3-yl]-propionic acid |
| 04/24/2008 | US20080096908 Nitrate derivatives of atorvastatin with improved pharmacological activity and enhanced tolerability; coronary syndromes, neurodegenerative disorders, and for reducing cholesterol levels; antiinflammatory, antithrombotic and antiplatelet activity; fluvastatin 4-(nitrooxy)butyl ester |
| 04/24/2008 | US20080096887 Benzene, Pyridine, and Pyridazine Derivatives |
| 04/24/2008 | US20080096878 CGRP (Calcitonin Gene-Related Peptide); migraine and cluster headaches; 2-(5-Bromo-1'1'-dioxido-2-oxo-2',3',5',6'-tetrahydrospiro[indole-3,4'-thiopyran]-1 (2H)-yl)-N-(2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide for example; use with other drugs |
| 04/24/2008 | US20080096877 Glucokinase activators; prophylaxis or treatment of diabetes, obesity; sulfonamide or sulfonate-functional thiazole or thiadiazole-substituted indoles; N,N-dimethyl-2-{4-[(2-{7-[methyl(2-thienylsulfonyl)amino]-1H-indol-2-yl}-1,3-thiazol-5-yl)methyl]piperazin-1-yl}acetamide for example |
| 04/24/2008 | US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 04/24/2008 | US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/24/2008 | US20080096115 For resist applications; thermostability, storage stability; color filters |
| 04/24/2008 | US20080093987 Organoelectroluminescent compound and organoelectroluminescent device employing the same |
| 04/24/2008 | CA2666149A1 Substituted indoles |
| 04/23/2008 | EP1912970A2 Acyltryptophanols for fertility control |
| 04/23/2008 | EP1912953A1 Process for the synthesis of rosuvastatin calcium |
| 04/23/2008 | EP1912940A1 Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
| 04/23/2008 | EP1912939A1 Metabotropic glutamate-receptor-potentiating isoindolones |
| 04/23/2008 | EP1912706A2 Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101166723A New compound for the treatinginflammatory disease |
| 04/23/2008 | CN101166722A Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles |
| 04/23/2008 | CN101166721A 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 04/23/2008 | CN101165051A Dendritic main body material and organic electroluminescence device prepared from the same |
| 04/23/2008 | CN101165050A Benzoisoindole derivative, pigment composition comprising the same and colored composition |
| 04/23/2008 | CN101165049A Crystalline sulfonamide-containing indole compound |
| 04/23/2008 | CN101165048A Method for preparing polyisocyanic acid ester |
| 04/23/2008 | CN100383160C Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 04/23/2008 | CN100383159C Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 04/23/2008 | CN100383151C Iridium complex of beta-diketone ligand and its electroluminescent device |
| 04/23/2008 | CN100383138C Novel n-monoacylated o-phenylenediamines, their condensed heterocyclic derivatives and their use as pharmaceutical agents |
| 04/23/2008 | CN100383119C Process for preparation of optically active indoline-2-carboxylic acid or derivative thereof |
| 04/23/2008 | CN100383110C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
| 04/22/2008 | US7361783 Agonists for human PPAR alpha isoform; exhibit lipid-lowering effect, inhibitory effect on the arteriosclerosis, antiobesity effect, blood glucose-lowering effect; 2-{[3-(N-{[4-(3,5-bistrifluoromethylphenoxy)phenyl]methyl}carbamoyl)-4-methoxyphenyl]methyl}butyric acid |
| 04/22/2008 | US7361767 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 04/22/2008 | US7361701 Aliphatic polyester composition, a molded article thereof and a method for controlling biodegradation rate using the same composition |
| 04/22/2008 | US7361682 Indole derivatives as H3 inverse agonists |
| 04/22/2008 | US7361681 Method of treating amytrophic lateral sclerosis using melatonin |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361198 oxidative hair colorants; which particularly in combination with the often used p-phenylenediamines would give blue shades and afford oxidation colorants with high resistance to external influences, particularly to frequent washing and sunlight |
| 04/22/2008 | CA2350137C New piperazine and di-dehydropiperidine compounds |
| 04/17/2008 | WO2008045671A1 Matrix metalloprotease inhibitors |
| 04/17/2008 | WO2008045529A1 Purine and pyrimidine derivatives for treatment of cancer and inflammatory diseases |
| 04/17/2008 | WO2008045371A2 N-substituted-azacyclylamines as histamine-3 antagonists |
| 04/17/2008 | WO2008044339A1 Therapeutic/preventive agent for intraocular disease containing statin compound |
| 04/17/2008 | WO2008044243A2 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof |
| 04/17/2008 | WO2008044045A1 Pharmaceutical combinations |
| 04/17/2008 | WO2008044034A1 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 04/17/2008 | WO2008043698A1 Vinylogous acids derivatives as chymase inhibitors |
| 04/17/2008 | WO2008010238A3 Antidiabetic azabicyclo [3. 1. 0] hexan compounds |
| 04/17/2008 | WO2007147771A3 Tetralin and indane derivatives and uses thereof |
| 04/17/2008 | WO2007144785A3 Ryanodine receptor inhibitors and methods relating thereto |
| 04/17/2008 | WO2007060374A3 Method for controlled free radical polymerization or copolymerization of methacrylic and/or methacrylate monomers for producing methacrylic or methacrylate polymers or exclusively methacrylic and/or methacrylate copolymers |
| 04/17/2008 | US20080091032 aldol reacting indole-3-pyruvic acid and oxalacetic acid/pyruvic acid and decarboxylating; for producing monatin for use in sweeteners and drugs |
| 04/17/2008 | US20080091031 Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates |
| 04/17/2008 | US20080091030 Stilbene Derivatives, Light-Emitting Element, Display Device, and Electronic Device |
| 04/17/2008 | US20080091015 Use of squaraine dyes to visualize protein during separations |
| 04/17/2008 | US20080090978 Ligand of cyclopentadiene fused to heterocycle with atom(s) of boron, nitrogen, oxygen, aluminum, silicon, phosphorus, sulfur, gallium, germanium, arsenic, selenium, indium, tin, antimony and/or tellurium; coordination catalysts; isotatic, syndiotactic or atactic polyethylene, polypropylene or copolymer |
| 04/17/2008 | US20080090871 Cannabimimetic indole derivatives |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090857 Statin derivatives |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | US20080087327 Organic dye, photoelectric conversion material, semiconductor electrode and photoelectric conversion device |
| 04/17/2008 | US20080087192 Phthalocyanine dyes suitable for use in offset inks |
| 04/17/2008 | CA2665931A1 Hydrobenzamide derivatives as inhibitors of hsp90 |
| 04/17/2008 | CA2665071A1 N-substituted-azacyclylamines as histamine-3 antagonists |
| 04/17/2008 | CA2665046A1 Vinylogous acids derivatives as chymase inhibitors |